Teva Pharmaceutical Industries Ltd TEVA:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:28 PM EST
10.75quote price arrow down-0.01 (-0.09%)
Volume
311,765
Close
10.76quote price arrow down-0.24 (-2.18%)
Volume
7,611,172
52 week range
6.25 - 13.49

...

Loading . . .

KEY STATS

  • Open10.93
  • Day High10.99
  • Day Low10.57
  • Prev Close11.00
  • 52 Week High13.49
  • 52 Week High Date02/26/20
  • 52 Week Low6.25
  • 52 Week Low Date03/18/20
  • Market Cap11.798B
  • Shares Out1.097B
  • 10 Day Average Volume11.52M
  • Dividend0.00
  • Dividend Yield-
  • Beta1.44
  • 1 Year % Change-17.36

RATIOS/PROFITABILITY

  • EPS (TTM)-3.64
  • P/E (TTM)-2.95
  • Fwd P/E (NTM)4.29
  • EBITDA (MRQ)4.72B
  • ROE (MRQ)-33.25%
  • Revenue (MRQ)16.658B
  • Gross Margin (MRQ)46.75%
  • Net Margin (MRQ)-25.44%
  • Debt To Equity (MRQ)258.52%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date11/27/2017
  • Div Amount0.085
  • Split Date-
  • Split Factor-

Latest Teva Pharmaceutical Industries Ltd News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract...
Sol Barer Ph.D.
Chairman
Kaare Schultz
President
Eliyahu Kalif
Chief Financial Officer
Sven Dethlefs Ph.D.
Executive Vice President
Gianfranco Nazzi
Executive Vice President
Address
5 Bazel St, P O B 3190
Petah Tikva
49131
Israel